Case report: Tocilizumab for hypersensitivity reaction after oxaliplatin in a patient with NK/T-cell lymphoma

Case report: Tocilizumab for hypersensitivity reaction after oxaliplatin in a patient with NK/T-cell lymphoma

Oxaliplatin-induced hypersensitivity reactions (HSRs) are commonly encountered in first-line therapies for various malignancies. Recent research indicates that these reactions can include cytokine release reactions (CRRs), which are characterized by a marked increase in interleukin-6 (IL-6) levels,...

Full description

Saved in:
Bibliographic Details
Main Authors: Juanyan Liao, Ming Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
tocilizumab
hypersensitivity reaction
oxaliplatin
NK/T-cell lymphoma
IL-6
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1471038/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items